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Aquatic birds are the natural reservoir of influenza virus.
To date, 16 influenza subtypes have been identified in wild
birds.
These studies involved the characterization of
influenza A viruses obtained from the American Type
Culture Collection (ATCC) that had been collected from
wild birds. Virus stocks of each influenza virus isolate were
prepared and characterized for hemagglutinin (HA) and
neuraminidase (NA) activity. Influenza virus HA binds to
cellular receptors in the respiratory tract to initiate the
infection. Viral NA aids in the release of virus from infected
cells. HA activity was determined using red blood cells
from different species, and NA activity was measured by
enzyme assay.
These studies will determine if virus
subtypes collected from different species of birds and
different locations show any differences in HA or NA
activity. These studies will also evaluate antiviral drug
sensitivity and determine if virus isolates from wild birds
have similar drug sensitivity profiles to human clinical
isolates.
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Table 1: Influenza Virus Isolates from Wild Birds
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INTRODUCTION
The influenza virus is of great interest because of its
capacity to pass easily from one individual to another.
One proposed cause of this is neuraminidase (NA)
activity.
NA is an enzyme that is attached to the
membrane of the influenza virus. The activity of NA is
critical for the virus to release itself from infected cells [1].
This in turn will cause subsequent virus spread. NA has
also been proposed to aid in the entry of the virus into
target cells [2]. The roles of NA in influenza is important
for its success and ability to cause disease. This research
was to determine if NA activity differed among strains
collected at different times and regions from varying
species of wild birds. A focus of current chemotherapeutic
treatment regimen involves inhibiting the activity of the NA
enzyme. These antiviral drugs are called neuraminidase
inhibitors. Influenza has shown an incredible increase of
resistance to oseltamivir, a type of NA inhibitor. In the
2007 - 2008 winter, the virus tested positive for resistance
11% of the time from throat swabs of patients with the
most common influenza subtype [3]. This research looked
for a pattern in NA activity between isolates collected from
wild type birds to determine if there is correlation between
Influenza virus from wild birds compared to Influenza virus
found in humans.

Figure 1: Influenza Virus Model
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Figure 4: Effect of Oseltamivir on NA

FUTURE STUDIES
1. Neuraminidase (NA) assay using the NA Star kit (enzyme
assay) on 22 viruses from wild birds.
2. Hemagglutinin (HA) assay on all the virus isolates using red
blood cells (RBCs).
3. Cell-culture based (96-well plate) antiviral assay evaluating
sensitivity to oseltamivir and amantidine.
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Figure 2: NA-Star® Influenza Neuraminidase Inhibitor
Resistance Detection Kit
Viral neuraminidase inhibition assay
The effect of oseltamivir on viral neuraminidase activity was
performed using a commercially available kit (NA-Star®Influenza
Neuraminidase Inhibitor Resistance Detection Kit, Applied
Biosystems, Foster City, CA) in 96-well solid white microplates
following the manufacturer’s instructions. Oseltamivir in half-log
dilution increments was incubated with virus (as the source of
neuraminidase). The amount of virus in each was approximately
500 cell culture infectious doses (CCID50). Following addition of
substrate plates were incubated for 10 min at 37oC. The
neuraminidase activity was evaluated using a Centro LB 960
luminometer (Berthold Technologies) for 0.5 sec immediately after
addition of NA-Star® accelerator solution.
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